Data Composite

Liraglutide Injection Shortage

9 of 10 tracked records currently active across 4 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Hikma Pharmaceuticals USA, Inc. LIRAGLUTIDE Current 07/13/2026
Hikma Pharmaceuticals USA, Inc. LIRAGLUTIDE Current 07/13/2026
Novo Nordisk, Inc. SAXENDA Current 06/08/2026
Novo Nordisk, Inc. VICTOZA Current 06/08/2026
Novo Nordisk, Inc. VICTOZA Current 06/08/2026
Novo Nordisk, Inc. LIRAGLUTIDE Current 06/08/2026
Novo Nordisk, Inc. LIRAGLUTIDE Current 06/08/2026
Meitheal Pharmaceuticals, Inc. LIRAGLUTIDE Current 06/01/2026
Meitheal Pharmaceuticals, Inc. LIRAGLUTIDE Current 06/01/2026
Teva Pharmaceuticals USA, Inc. LIRAGLUTIDE To Be Discontinued 05/14/2026

← All shortages